We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

593 hedge funds and large institutions have $2.46B invested in iShares US Medical Devices ETF in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 167 increasing their positions, 234 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 37.87%37.95% (+0.08%)

6% less funds holding

Funds holding: 632593 (-39)

17% less capital invested

Capital invested by funds: $2.96B → $2.46B (-$504M)

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

27% less call options, than puts

Call options by funds: $14.6M | Put options by funds: $19.9M

29% less repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 234

39% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 84

Holders
593
Holders Change
-39
Holders Change %
-6.17%
% of All Funds
9.99%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.3%
New
51
Increased
167
Reduced
234
Closed
84
Calls
$14.6M
Puts
$19.9M
Net Calls
-$5.36M
Net Calls Change
-$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
SEIA
301
Signature Estate & Investment Advisors
California
$534K -$85.7K -1,572 -13%
SA
302
Strategic Advisors
New York
$533K -$8.18K -150 -1%
GWSG
303
GPS Wealth Strategies Group
Colorado
$530K -$230K -4,228 -29%
Barclays
304
Barclays
United Kingdom
$526K -$899K -16,500 -61%
PWW
305
Pettyjohn Wood & White
Virginia
$526K
WWP
306
WR Wealth Planners
Missouri
$525K -$65.2K -1,196 -10%
HFP
307
Holistic Financial Partners
Indiana
$524K -$1.44M -26,429 -72%
PWA
308
Physician Wealth Advisors
Utah
$524K +$38.8K +711 +8%
SFS
309
Security Financial Services
Indiana
$508K -$638K -11,705 -54%
M&T Bank
310
M&T Bank
New York
$506K
VWA
311
V Wealth Advisors
Kansas
$503K +$31.4K +577 +6%
GIA
312
Gladstone Institutional Advisory
Florida
$502K -$137K -2,508 -20%
BNP Paribas Financial Markets
313
BNP Paribas Financial Markets
France
$500K -$1.07M -19,604 -66%
FFN
314
Focus Financial Network
Minnesota
$500K -$169K -3,098 -24%
MFG
315
Magnus Financial Group
New York
$495K -$12.7K -233 -2%
BBL
316
Beck Bode LLC
Massachusetts
$495K +$51.3K +941 +11%
CCA
317
Cadent Capital Advisors
Oklahoma
$494K +$491 +9 +0.1%
MAP
318
Milestone Advisory Partners
North Carolina
$487K -$98.1K -1,800 -16%
SWA
319
Stratos Wealth Advisors
Ohio
$485K -$652K -11,968 -55%
LFAS
320
Level Four Advisory Services
Texas
$475K -$112K -2,063 -18%
BBA
321
BLB&B Advisors
Pennsylvania
$474K +$114K +2,090 +29%
OFG
322
OmniStar Financial Group
North Carolina
$472K +$218 +4 +0%
PWA
323
PCG Wealth Advisors
Kansas
$470K +$2.02K +37 +0.4%
AA
324
Ancora Advisors
Ohio
$469K -$25.6K -470 -5%
OCM
325
One Capital Management
California
$464K -$67K -1,230 -12%

IHI Hedge Fund Activity: Q2 2022 in Review

593 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2022, worth a combined $2.46B — down 17% from $2.96B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of IHI and 51 opened new positions — a net loss of 33 holders — while 234 trimmed existing stakes and 167 added.

The largest buyer was AssetMark Inc, adding an estimated $78.4M. The largest seller was CFS Investment Advisory Services, cutting an estimated $88.9M.

  • 593 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2022, down from 632 in Q1 2022.
  • Funds reported $2.46B of iShares US Medical Devices ETF stock for Q2 2022, down 17% quarter-over-quarter.
  • 51 funds opened new iShares US Medical Devices ETF positions in Q2 2022 and 84 closed out, a net change of -33 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2022 was AssetMark Inc, an estimated $78.4M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2022 was CFS Investment Advisory Services, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2022.